Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management

Despite the important role of high-intensity statins in reducing atherosclerotic cardiovascular disease events in secondary and primary prevention, substantial residual risk persists, particularly among high-risk patients with type 2 diabetes mellitus, metabolic syndrome, and obesity. Considerable a... View More